Advertisement

Topics

WHO prequalifies first generic hepatitis C drug

05:37 EDT 18 Aug 2017 | Generics and Biosimilars Initiative

The World Health Organization (WHO) has pre-qualified the first generic drug to treat hepatitis C. The antiviral agent sofosbuvir will be manufactured at a lower cost by Mylan.

Original Article: WHO prequalifies first generic hepatitis C drug

NEXT ARTICLE

More From BioPortfolio on "WHO prequalifies first generic hepatitis C drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...